American Association for Cancer Research (AACR) Annual Meeting
Wednesday, April 22, 2015, 10:00 AM -12:00 PM
Room 121, Pennsylvania Convention Center, Philadelphia, PA
CME/CE Hours: 2
The Clinical Proteomic Tumor Analysis Consortium (CPTAC) has completed the generation of deep proteomic analysis on genomically characterized tumors from The Cancer Genome Atlas (TCGA). The resulting data from three cancer types - colorectal, breast and ovarian, has revealed new molecular subtype classifications and identified novel non-genomic drivers with possible targets and pathways of cancer detection and intervention. This session is dedicated to presenting the results of the deep proteomic analyses of these cancer types (with genomic integration), and helping cancer scientists learn how to access the high-throughput data sets from CPTAC.
PRESENTATIONS:
- Chairpersons
- Douglas R. Lowy (NCI Acting Director). National Cancer Inst., Bethesda, MD
- Steven A. Carr. Broad Institute of Harvard and MIT, Cambridge, MA
- Proteogenomic analysis of human colon and rectal cancer
- Daniel C. Liebler. Vanderbilt University, Nashville, TN
- Proteogenomic and phosphoproteomic analysis of breast cancer
- Philipp Mertins. Broad Institute of Harvard and MIT, Cambridge, MA
- Proteogenomic and phosphoproteomic analysis of ovarian cancer
- Karin D. Rodland. Pacific Northwest National Laboratory, Richland, WA
- Targeted MRM mass spectrometry enables highly multiplexed quantification of cell signaling in response to DNA damage
- Amanda G. Paulovich. Fred Hutchinson Cancer Research Center, Seattle, WA
For more information, please visit the AACR website.
Henry Rodriguez (OCCPR Director). National Cancer Inst., Bethesda, MD